Sobre MRK
Merck & Co., Inc. opera as a líder healthcare company em todo o mundo, focando em human health pharmaceuticals, vaccines, e animal health produtos. Its portfolio includes blockbuster drugs like Keytruda for immuno-oncology, Gardasil for human papillomavirus prevention, e a range of treatments como Welireg, ProQuad, Winrevair, Januvia, e others addressing cancer, infectious diseases, cardiometabolic conditions, e more. A empresa also fornece veterinary solutions incluindo Nuflor e Bovilis for livestock health management. Com um substancial presence in oncology, its Keytruda leads sales contributions, complemented by vaccines targeting pediatric diseases. Merck & Co., Inc. generates significant revenue—$64.17 billion in 2024—from pharmaceuticals e vaccines, primarily na U.S., while maintaining a diversified global footprint em consumer, business, e government sectors. Com cerca de 75,000 funcionários, it desempenha um papel central in advancing treatments for chronic e infectious diseases, driving innovation in biopharmaceuticals e immunotherapy.
